Strong partnerships are often the catalyst for meaningful progress. To strengthen these connections and reward those who help expand our network, we’ve launched a structured and transparent Referral Program designed to create genuine win win outcomes for everyone involved.
For medical device companies, choosing whether to outsource to a CRO is a strategic decision. The “right answer” depends on your stage, device type, regulatory markets, internal capabilities, budget and speed-to-market ambitions.
XPER is proud to announce its new partnership with lifetech.brussels, a leading accelerator for digital health, medtech and life sciences innovation in the Brussels region. By becoming a partner of lifetech.brussels, XPER will work closely with start-ups and scale-ups seeking guidance on how to design, prepare, and execute clinical strategies that
This blog post provides an overview of the different types of clinical investigations as defined by the MDR, providing a comprehensive overview of each category.
For years, the trend has been “US-first” for medical device clinical studies. However, it’s worth taking a fresh look at Europe as a valuable clinical development location. And here’s why.
The acquisition of Lorentis reinforces XPER’s commitment to become the go-to boutique CRO for the MedTech and IVD sector across the globe.
XPER Research welcomes three new managing partners, strengthening its leadership and reinforcing its position as a leading boutique MedTech CRO.
